Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2009-04-15
2011-11-15
Whiteman, Brian (Department: 1635)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C536S024500
Reexamination Certificate
active
08058069
ABSTRACT:
The present invention provides novel, stable lipid particles comprising one or more active agents or therapeutic agents, methods of making the lipid particles, and methods of delivering and/or administering the lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) comprising a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP.
REFERENCES:
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4438052 (1984-03-01), Weder et al.
patent: 4515736 (1985-05-01), Deamer
patent: 4598051 (1986-07-01), Papahadjopoulos et al.
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5171678 (1992-12-01), Behr et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5225212 (1993-07-01), Martin et al.
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5279833 (1994-01-01), Rose
patent: 5283185 (1994-02-01), Epand et al.
patent: 5320906 (1994-06-01), Eley et al.
patent: 5545412 (1996-08-01), Eppstein et al.
patent: 5578475 (1996-11-01), Jessee et al.
patent: 5641662 (1997-06-01), Debs et al.
patent: 5656743 (1997-08-01), Busch et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5705385 (1998-01-01), Bally et al.
patent: 5820873 (1998-10-01), Choi et al.
patent: 5976567 (1999-11-01), Wheeler et al.
patent: 5981501 (1999-11-01), Wheeler et al.
patent: 6534484 (2003-03-01), Wheeler et al.
patent: 6586410 (2003-07-01), Wheeler et al.
patent: 6649780 (2003-11-01), Eibl et al.
patent: 6815432 (2004-11-01), Wheeler et al.
patent: 6858224 (2005-02-01), Wheeler et al.
patent: 7422902 (2008-09-01), Wheeler et al.
patent: 7799565 (2010-09-01), MacLachlan et al.
patent: 7807815 (2010-10-01), MacLachlan et al.
patent: 7838658 (2010-11-01), MacLachlan et al.
patent: 2001/0048940 (2001-12-01), Tousignant et al.
patent: 2003/0077829 (2003-04-01), MacLachlan
patent: 2003/0143732 (2003-07-01), Fosnaugh et al.
patent: 2004/0063654 (2004-04-01), Davis et al.
patent: 2004/0142892 (2004-07-01), Finn et al.
patent: 2004/0253723 (2004-12-01), Tachas et al.
patent: 2004/0259247 (2004-12-01), Tuschl et al.
patent: 2005/0064595 (2005-03-01), MacLachlan et al.
patent: 2005/0118253 (2005-06-01), MacLachlan et al.
patent: 2006/0008910 (2006-01-01), MacLachlan et al.
patent: 2007/0042031 (2007-02-01), MacLachlan et al.
patent: 2009/0291131 (2009-11-01), Maclachlan et al.
patent: WO 91/16024 (1991-10-01), None
patent: WO 93/05162 (1993-03-01), None
patent: WO 93/12240 (1993-06-01), None
patent: WO 93/12756 (1993-07-01), None
patent: WO 93/24640 (1993-12-01), None
patent: WO 93/25673 (1993-12-01), None
patent: WO 95/02698 (1995-01-01), None
patent: WO 95/18863 (1995-07-01), None
patent: WO 95/35301 (1995-12-01), None
patent: WO 96/02655 (1996-02-01), None
patent: WO 96/10390 (1996-04-01), None
patent: WO 96/40964 (1996-12-01), None
patent: WO 96/41873 (1996-12-01), None
patent: WO 01/05374 (2001-01-01), None
patent: WO 02/034236 (2002-05-01), None
patent: WO 02/087541 (2002-11-01), None
patent: WO 03/097805 (2003-11-01), None
patent: WO 2004/065546 (2004-08-01), None
patent: WO 2004/110499 (2004-12-01), None
patent: WO 2005/007196 (2005-01-01), None
patent: WO 2005/026372 (2005-03-01), None
patent: WO 2005/120152 (2005-12-01), None
patent: WO 2009/086558 (2009-07-01), None
patent: WO 2009/111658 (2009-09-01), None
patent: WO 2010/042877 (2010-04-01), None
patent: WO 2010/048228 (2010-04-01), None
patent: WO 2010/088537 (2010-08-01), None
patent: WO 2010/105209 (2010-09-01), None
Arpicco, S., et al., “Preparation and Characterization of Novel Cationic Lipids Developed for Gene Transfection,” Proceed. Int'l Symp. Control. Rel. Bioact. Mater. (Controlled Release Society, Inc.), 1999, vol. 26, pp. 759-760.
Arpicco, S., et al., “Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids,” IL Farmaco, 2004, vol. 59, pp. 869-878.
Ballas, N., et al., “Liposomes bearing a quatemary ammonium detergent as an efficient vehicle for functional transfer of TMV-RNA into plant protoplasts,” Biochimica et Biophysica Acta, 1988, vol. 939, pp. 8-18.
Barinaga, M., “Step Taken Toward Improved Vectors for Gene Transfer,” Science, 1994, vol. 266, p. 1326.
Bass,Nature, 2001, 411: 428-9.
Beale, G., et al., “Gene Silencing Nucleic Acids Designed by Scanning Arrays: Anti-EGFR Activity of siRNA, Ribozyme and DNA Enzymes Targeting a Single Hybridization-accessible Region using the Same Delivery System,” Journal of Drug Targeting, 2003, vol. 11, No. 7, pp. 449-456.
Behr, J.-P., “Synthetic Gene-Transfer Vectors,” Acc. Chem. Res., 1993, vol. 26, pp. 274-278.
Brigham, K., et al., “Rapid Communication: In vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene Using a Liposome Vehicle,” The American Journal of the Medical Sciences, vol. 298, No. 4, pp. 278-281, 1989.
Brummelkamp, et al., “A System for Stable Expression of Short Interfering RNAs in Mammalian Cells,” Science, 2002, V. 296. pp. 550-553.
Cevc, G., “How Membrane Chain-Melting Phase-Transition Temperature is Affected by the Lipid Chain Asymmetry and Degree of Unsaturation: An Effective Chain-Length Model,” Biochemistry, 1991, vol. 30, pp. 7186-7193.
Cortesi, R., et al., “Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA,” International Journal of Pharmaceutics, 1996, vol. 139, pp. 69-78.
Crystal, R., “Transfer of Genes to Humans: Early Lessons and Obstacles to Success,” Science, 1995, vol. 270, pp. 404-410.
Culver K., “The First Human Gene Therapy Experiment,” Gene Therapy: A Handbook for Physicians, 1994, pp. 33-40.
Duzgunes, N., “Membrane Fusion,” Subcellular Biochemistry, 1985, vol. 11, pp. 195-286.
Dwarki, V.J., et al., “Cationic Liposome-Mediated RNA Transfection,” Methods in Enzymology, 1993, vol. 217, pp. 644-654.
Enoch, H., et al., “Formation and properties of 1000-Å-diameter, single-bilayer phospholipid vesicles,” Proc. Natl. Acad. Sci. USA, 1979, vol. 76, No. 1, pp. 145-149.
Felgner, J., et al., “Cationic Lipid-Mediated Transfection in Mammalian Cells: ‘Lipofection,’” J. Tiss. Cult. Meth., 1993, vol. 15, pp. 63-68.
Felgner, J., et al., “Enhanced Gene Delivery and Mechanism Studies with a Novel Series of Cationic Lipid Formulations,” The Journal of Biological Chemistry, 1994, vol. 269, No. 4, pp. 2550-2561.
Felgner, P., et al., “Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure,” Proc. Natl. Acad. Sci. USA, 1987, vol. 84, pp. 7413-7417.
Felgner, P.L., et al., “Cationic Liposome Mediated Transfection,” Proc. West. Pharmacol. Soc., 1989, vol. 32, pp. 115-121.
Gao, X., et al., “A Novel Cationic Liposome Reagent for Efficient Transfection of Mammalian Cells,” Biochem. Biophys. Res. Comm., 1991, vol. 179, No. 1, pp. 280-285.
Gershon, H., et al., “Mode of Formation and Structural Feature of DNA-Cationic Liposome Complexes Used for Transfection,” Biochemistry, 1993, vol. 32, pp. 7143-7151.
Guy-Caffey, J., et al., “Novel Polyaminolipids Enhance the Cellular Uptake of Oligonucleotides,” The Journal of Biological Chemistry, 1995, vol. 270, No. 52, pp. 31391-31396.
Hawley-Nelson, P., et al., “LipofectAmine™ Reagent: A New, Higher Efficiency Polycationic Liposome Transfection Reagent,” Focus, 1993, vol. 15, No. 3, pp. 73-80.
Hyde, S., et al., “Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy,” Nature, 1993, vol. 362, pp. 250-255.
Jiang, L., et al., “Comparison of protein precipitation methods for sample preparation prior to proteomic analysis,” Journal of Chromatography A, 2004, vol. 1023, pp. 317-320.
Juliano, R., et al., “The Effect of Particle Size
Jeffs Lloyd
Lam Kieu
MacLachlan Ian
Palmer Lorne
Yaworski Edward
Kilpatrick Townsend & Stockton LLP
Protiva Biotherapeutics Inc.
Whiteman Brian
LandOfFree
Lipid formulations for nucleic acid delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipid formulations for nucleic acid delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipid formulations for nucleic acid delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4266074